Home › Funds › TANG CAPITAL MANAGEMENT LLC › RCKT

TANG CAPITAL MANAGEMENT LLC position in RCKT

ROCKET PHARMACEUTICALS INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 100,000 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$263K, representing 0.01% of its reported portfolio and ranking #45 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed RCKT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)100.00K sh
Reported value held$263.00K
Portfolio Weight0.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's RCKT position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in RCKT in Q3 2023 at 150,000 shares (US$3.1M). The position peaked in Q1 2024 at 660,000 shares, worth US$17.8M. Across 13 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$263K. Notable position changes include a 67% increase in Q4 2023 (shares fell 10% over the following quarter), a 164% increase in Q1 2024 (shares fell 20% over the following quarter), a 88% trim in Q4 2025 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 150.00K $3.07M New
Q4 2023 250.00K $7.49M Add
Q1 2024 660.00K $17.78M Add
Q2 2024 750.00K $16.15M Add
Q3 2024 750.00K $13.85M Hold
Q4 2024 750.00K $9.43M Hold
Q1 2025 850.00K $5.67M Add
Q2 2025 850.00K $2.08M Hold
Q3 2025 850.00K $2.77M Hold
Q4 2025 100.00K $351.00K Reduce
Q1 2026 100.00K $358.00K Hold
Q2 2026 100.00K $342.00K Hold
Q3 2026 100.00K $263.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCKT and 13F data

RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 14 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$46.5M), Maverick Capital (US$13.4M), Newtyn Management, LLC (US$10.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCKT

All RCKT fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held RCKT?

TANG CAPITAL MANAGEMENT LLC has disclosed RCKT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in RCKT?

As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 100.00K shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $263.00K, representing 0.01% of its reported portfolio and ranking #45.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling RCKT?

In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in RCKT. The position peaked in Q1 2024 at 660.00K shares.

Which other funds hold RCKT?

Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Maverick Capital, Newtyn Management, LLC, among 14 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.